Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Jonathan Biller

At a glance: Jonathan Biller is General Counsel at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Feb 26, 2026, reported a sale of $460K. On file: 0 purchase lines ($0) and 7 sale lines ($4.1M).

Disclosed holdings: about $7.1M of VRTX stock: 13,659 shares reported on their latest Form 4 (filed Feb 26, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

General Counsel at Vertex Pharmaceuticals Inc / Ma (VRTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.1M

Jonathan Biller's InsiderPrint

7 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Jonathan Biller: 7 trades, 2025 to 20262025: 0 buys, 2 sales2026: 0 buys, 5 sales

Reading this print: Almost only sells, trading about 7 times a year, typically $493K a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (7)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Jennifer WuamettGeneral Counsel · NXPI · 100% match
  2. Joseph H. WenderDirector · IONS · 100% match
  3. Joseph ShulmanChief Technical Officer · RYTM · 100% match
  4. Joseph Anthony Mara Jr.CFO · VCEL · 100% match
  5. Mark Andrew SmithCFO · CMI · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Feb 26SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 94513,659 held (−6%) $486.35 $460K +7.2%
Feb 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,47616,992 held (−13%) $489.46 $1.2M +6.5%
Feb 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,24415,748 held (−7%) $473.68 $589K +10.1%
Feb 18SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 98816,838 held (−6%) $499.00 $493K +4.5%
Feb 12SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,92520,819 held (−8%) $460.43 $886K +13.2%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 34715,306 held (−2%) $449.00 $156K +16.1%
Oct 3SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 69415,653 held (−4%) $404.21 $281K +29.0%
  • Sell

    General Counsel Jonathan Biller sold $460K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jonathan Biller sold $1.2M of VRTX at $489.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jonathan Biller sold $589K of VRTX at $473.68 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jonathan Biller sold $493K of VRTX at $499.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jonathan Biller sold $886K of VRTX at $460.43 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jonathan Biller sold $156K of VRTX at $449.00 — pre-scheduled 10b5-1 plan sale.

Follow Jonathan Biller

Get one email when Jonathan Biller files a new purchase or sale. Free.

At most one email a day about Jonathan Biller, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.